Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort - Top-Institutions - MDSpire

Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort

  • By

  • Alessandro Conforti

  • Martina Gentile

  • Valerio Cipolloni

  • Linda Lucchetti

  • Marta Priora

  • Andrea Becciolini

  • Eleonora Celletti

  • Miriam Di Penta

  • Alberto Lo Gullo

  • Marino Paroli

  • Elena Bravi

  • Romina Andracco

  • Valeria Nucera

  • Francesca Ometto

  • Federica Lumetti

  • Antonella Farina

  • Matteo Colina

  • Viviana Ravagnani

  • Palma Scolieri

  • Maddalena Larosa

  • Elisa Visalli

  • Olga Addimanda

  • Rosetta Vitetta

  • Alessandro Volpe

  • Alessandra Bezzi

  • Francesco Girelli

  • Aldo Biagio Molica Colella

  • Rosalba Caccavale

  • Eleonora Di Donato

  • Giuditta Adorni

  • Daniele Santilli

  • Gianluca Lucchini

  • Eugenio Arrigoni

  • Emanuela Sabatini

  • Ilaria Platè

  • Natalia Mansueto

  • Aurora Ianniello

  • Enrico Fusaro

  • Maria Chiara Ditto

  • Vincenzo Bruzzese

  • Dario Camellino

  • Gerolamo Bianchi

  • Francesca Serale

  • Rosario Foti

  • Giorgio Amato

  • Francesco De Lucia

  • Ylenia Dal Bosco

  • Roberta Foti

  • Massimo Reta

  • Alessia Fiorenza

  • Guido Rovera

  • Antonio Marchetta

  • Maria Cristina Focherini

  • Fabio Mascella

  • Simone Bernardi

  • Gilda Sandri

  • Dilia Giuggioli

  • Carlo Salvarani

  • Veronica Franchina

  • Francesco Molica Colella

  • Giulio Ferrero

  • Mirco Magnani

  • Marta Maset

  • Camilla Mazzanti

  • Gianluca Santoboni

  • Claudio Angrisani

  • Massimiliano De Simone

  • Bernd Raffeiner

  • Simone Parisi

  • Alarico Ariani

  • July 8, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    BIRRA (BIologics Retention Rate Assessment) cohort
    BIRRA (BIologics Retention Rate Assessment) cohort

    N/A, N/A

    Key Differentiators

    • Rheumatology
  • #2

    Comitato Etico dell'Area Vasta Emilia Nord
    Comitato Etico dell'Area Vasta Emilia Nord

    N/A, N/A

    Key Differentiators

    • Ethics
  • #3

    OPAL Rheumatology
    OPAL Rheumatology

    N/A, N/A

    Key Differentiators

    • Rheumatology

Original Source(s)

Related Content